Skip to main content

In Significant Turnaround, DEA Announces Steps To Improve Access To Medical Marijuana Research

In a turn of events this week, the Drug Enforcement Administration (DEA) revealed that it is “moving forward to facilitate and expand scientific and medical research for marijuana in the United States.” To do this, the agency announced it will be accepting and reviewing applications from marijuana growers who would like their products to be used for scientific and medical research. This builds on a three-year-old commitment to end the 50-year monopoly held by the University of Mississippi, the country’s only approved grower per a contract by the National Institute on Drug Abuse (NIDA). A monopoly that has resulted in sub-par cannabis for testing, and thus the U.S. falling years behind the scientific work of other countries including China and Israel.

Nevertheless, many fear the announcement may be too good to be true for the time being given the years of delays and vague language used in the Federal Register notice. According to documents the agency wants to craft and roll out new rules for evaluating and overseeing new growers. Which could possibly signal a means of delaying real action.

The announcement did however get a full press release and quotes from Attorney General William P. Barr who said, “I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research.” He went on to include buy-in from other agencies saying, “The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”

This is a significant change from his predecessor Jeff Sessions’ position on the subject. It was well documented in 2017 that then Attorney General Sessions effectively blocked the DEA from pursuing at least 25 proposals (reportedly 33 applications have been filed since 2016) for growing marijuana for the purposes of medical and scientific research.

Further, according to the Department of Justice the number of researchers approved to conduct studies with marijuana grow from 384 in 2017 to 542 in 2019 (an increase of more than 40%) – suggesting that the DEA and the University of Mississippi are having to significantly increase the supply of marijuana used in research.

But supply and demand is not the only catalyst for movement on the part of the DEA. In fact, the announcement came just two days before the DEA had to file a response (court ordered) to a lawsuit brought by a research institute carrying out efforts to better understand  cannabis for treating post-traumatic stress (PTSD) in combat veterans. The Scottsdale Research Institute sued the DEA earlier in 2019 after their application for cultivating research-grade cannabis went ignored – along with all the other applications – for years.

In the coming days there is expected to be a public response from other heads of federal agencies, as well updates on the Scottsdale Research Institute’s lawsuit.

Original Article Source: https://www.forbes.com/sites/nicolefisher/2019/08/28/in-significant-turnaround-dea-announces-steps-to-improve-access-to-medical-marijuana-research/

Comments

Post a Comment

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...
Post a Comment
Read more